Herman Waldmann: Timeline of key events
Mouseover the event title for a more detailed description of the event (if available). To search for particular terms in the description of the event enter the term in the box below 'Event' on the table and press 'enter'. Alternatively use the dropdown lists to filter by Person, Place or Science. Click here to clear the filter.
|27 Feb 1945||Herman Waldmann was born in United Kingdom||Waldmann||United Kingdom|
|1980||First monoclonal antibodies developed against T-cells which can also activate human complement.||Waldmann, Cobbold, Hale, Metcalfe. Watt, Trang||Cambridge University||Monoclonal antibodies, Campath|
|1988||Campath-1H is created - the first clinically useful humanised monoclonal antibody.||Winter, Waldmann, Reichmann, Clark||Cambridge University, Laboratory of Molecular Biology||Monoclonal antibodies, Recombinant DNA, Campath|
|1988||Patent application filed for a method to create transgenic mice for the production of human antibodies||Bruggeman, Caskey, Neuberger, Surani, Teale, Waldmann, Williams||Laboratory of Molecular Biology, Babraham Institute, Cambridge University||Monoclonal antibodies, gene cloning, transgenic animals|
|Sep 2013||Campath-1H gains marketing approval for the treatment of MS.||Waldmann, Compston, Coles||Cambridge University||Campath|
27 Feb 1945
Herman Waldmann was born in United Kingdom
First monoclonal antibodies developed against T-cells which can also activate human complement.
Campath-1H is created - the first clinically useful humanised monoclonal antibody.
Patent application filed for a method to create transgenic mice for the production of human antibodies
Campath-1H gains marketing approval for the treatment of MS.